Browsing by Author Taper, John

Showing results 1 to 2 of 2
PreviewIssue DateTitleAuthor(s)
26-Mar-2024How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Tiong, Ing SooWall, MeaghanBajel, AshishKalro, AkashFleming, ShaunRoberts, Andrew WThiagarajah, NishaChua, Chong ChynLatimer, MayaYeung, DavidMarlton, PaulaJohnston, AmandaEnjeti, AnoopFong, Chun YewCull, GavinLarsen, StephenKennedy, GlenSchwarer, AnthonyKipp, DavidRamanathan, SundraVerner, EmmaTiley, Campbell Morris, EdwardHahn, UweMoore, JohnTaper, JohnPurtill, DuncanWarburton, PaulineStevenson, WilliamMurphy, Nicholas J Tan, PeterBeligaswatte, AshankaMutsando, HowardHertzberg, MarkShortt, JakeSzabo, FerencDunne, KarinWei, Andrew H
7-Dec-2023Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGLoo, SunRoberts, Andrew WAnstee, Natasha SKennedy, Glen AHe, SimonSchwarer, Anthony PEnjeti, Anoop KD'Rozario, JamesMarlton, PaulaBilmon, Ian ATaper, JohnCull, GavinTiley, Campbell Verner, EmmaHahn, UweHiwase, Devendra KIland, Harry JMurphy, NickRamanathan, SundraReynolds, JohnOng, Doen MingTiong, Ing SooWall, MeaghanMurray, MichaelRawling, TristanLeadbetter, JoannaRowley, LeesaLatimer, MayaYuen, SamTing, Stephen BFong, Chun YewMorris, KirkBajel, AshishSeymour, John FLevis, Mark JWei, Andrew H